Vagifem
Drug
Novo Nordisk Inc
Total Payments
$27,575
Transactions
15
Doctors
12
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $3,100 | 1 | 1 |
| 2022 | $13,657 | 2 | 1 |
| 2021 | $10,720 | 1 | 0 |
| 2018 | $37.98 | 3 | 3 |
| 2017 | $59.99 | 8 | 8 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $18,377 | 2 | 66.6% |
| Consulting Fee | $9,100 | 2 | 33.0% |
| Food and Beverage | $97.97 | 11 | 0.4% |
Payments by Type
Research
$18,377
2 transactions
General
$9,198
13 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Estrogen Replacement to Improve Genital Tract Mucosal Immunity in Menopausal Women | Novo Nordisk Inc | $18,377 | 0 |
Top Doctors Receiving Payments for Vagifem
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Bronx, NY | $18,377 | 2 |
| , M.D | Reproductive Endocrinology | Washington, DC | $9,100 | 2 |
| , MD | Internal Medicine | Suwanee, GA | $19.09 | 1 |
| , MD | Family Medicine | Binghamton, NY | $18.46 | 1 |
| , MD | Pediatrics | Silver Spring, MD | $13.02 | 1 |
| , M.D | Family Medicine | Mount Pleasant, TX | $9.76 | 1 |
| , M.D | Family Medicine | Mount Pleasant, TX | $9.76 | 1 |
| , M.D | Internal Medicine | Saint Louis, MO | $7.76 | 1 |
| , M.D | Internal Medicine | Saint Louis, MO | $7.76 | 1 |
| , D.O | Family Medicine | Livonia, MI | $5.50 | 1 |
| , D.O | Family Medicine | Livonia, MI | $5.50 | 1 |
| , M.D | Family Medicine | Tulare, CA | $0.68 | 1 |
| , M.D | Family Medicine | Tulare, CA | $0.68 | 1 |
Ad
Manufacturing Companies
- Novo Nordisk Inc $18,475
- Novo Nordisk Health Care AG $9,100
Product Information
- Type Drug
- Total Payments $27,575
- Total Doctors 12
- Transactions 15
About Vagifem
Vagifem is a drug associated with $27,575 in payments to 12 healthcare providers, recorded across 15 transactions in the CMS Open Payments database. The primary manufacturer is Novo Nordisk Inc.
Payment data is available from 2017 to 2023. In 2023, $3,100 was paid across 1 transactions to 1 doctors.
The most common payment nature for Vagifem is "Unspecified" ($18,377, 66.6% of total).
Vagifem is associated with 1 research study, including "Estrogen Replacement to Improve Genital Tract Mucosal Immunity in Menopausal Women" ($18,377).